clement

The Basel-based biopharmaceutical company Cellestia Biotech closed a CHF 8 million seed financing round. The funds will help Cellestia advance its lead cancer treatment CB-103…

US pharmaceutical company Johnson & Johnson is to acquire the biopharmaceutical company Actelion for USD 30 billion. Actelion’s research and development department will spin out…

The Basel-based biotechnology company Therachon has raised an additional USD 5 million in its latest financing round. It also appointed Luca Santarelli as its new…

The US investment firm Versant Ventures has launched a new fund worth USD 400 million with the aim of investing in 20 to 25 biotechnology…

The Basel-based pharmaceutical company PIQUR Therapeutics is entering into a partnership with the French pharmaceutical group Pierre Fabre to collaborate in the field of dermato-oncology.